Literature DB >> 33618052

Innate and Adaptive Immunity: ILC2 and Th2 Cells in Upper and Lower Airway Allergic Diseases.

Glenis K Scadding1, Guy W Scadding2.   

Abstract

Advances in our understanding of the immune system, with the recent discovery of a parallel set of innate T lymphocytes, the innate lymphocytes (ILCs), have led to a reassessment of the pathogenesis of allergic and eosinophilic airway disorders, including allergic rhinitis (AR), asthma, and chronic rhinosinusitis with nasal polyps. We review current understanding of both elements of type-2 inflammatory responses and their relative influence in these common conditions and consider possible impacts of this on treatment selection.
Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptive/acquired immunity; Allergic rhinitis; Asthma; Chronic rhinosinusitis with nasal polyps; Eosinophils; ILC2; Innate immunity; Th2

Year:  2021        PMID: 33618052     DOI: 10.1016/j.jaip.2021.02.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  7 in total

Review 1.  The Role of Allergen-Specific Immunotherapy in ENT Diseases: A Systematic Review.

Authors:  Elena Cantone; Stefania Gallo; Sara Torretta; Aikaterini Detoraki; Carlo Cavaliere; Claudio Di Nola; Luca Spirito; Tiziana Di Cesare; Stefano Settimi; Daniela Furno; Lorenzo Pignataro; Eugenio De Corso
Journal:  J Pers Med       Date:  2022-06-09

2.  Construction and analysis of a ceRNA network and patterns of immune infiltration in chronic rhinosinusitis with nasal polyps: based on data mining and experimental verification.

Authors:  Jing-Cai Chen; Qi-Long Xing; Hui-Wen Yang; Fan Yang; Yao Luo; Wei-Jia Kong; Yan-Jun Wang
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

3.  Immunoproteasome Inhibition Reduces the T Helper 2 Response in Mouse Models of Allergic Airway Inflammation.

Authors:  Franziska Oliveri; Michael Basler; Tata Nageswara Rao; Hans Joerg Fehling; Marcus Groettrup
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

4.  Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis.

Authors:  Corrado Pelaia; Nicola Lombardo; Maria Teresa Busceti; Giovanna Piazzetta; Claudia Crimi; Cecilia Calabrese; Alessandro Vatrella; Girolamo Pelaia
Journal:  J Asthma Allergy       Date:  2021-09-24

Review 5.  Allergic Rhinitis in Childhood and the New EUFOREA Algorithm.

Authors:  Glenis Kathleen Scadding; Peter Kenneth Smith; Michael Blaiss; Graham Roberts; Peter William Hellings; Philippe Gevaert; Marinda Mc Donald; Tania Sih; Suzanne Halken; Petra Ursula Zieglmayer; Peter Schmid-Grendelmeier; Erkka Valovirta; Ruby Pawankar; Ulrich Wahn
Journal:  Front Allergy       Date:  2021-07-14

Review 6.  (R)Evolution in Allergic Rhinitis Add-On Therapy: From Probiotics to Postbiotics and Parabiotics.

Authors:  Martina Capponi; Alessandra Gori; Giovanna De Castro; Giorgio Ciprandi; Caterina Anania; Giulia Brindisi; Mariangela Tosca; Bianca Laura Cinicola; Alessandra Salvatori; Lorenzo Loffredo; Alberto Spalice; Anna Maria Zicari
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

7.  Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy.

Authors:  Corrado Pelaia; Claudia Crimi; Santi Nolasco; Giovanna Elisiana Carpagnano; Raffaele Brancaccio; Enrico Buonamico; Raffaele Campisi; Claudia Gagliani; Vincenzo Patella; Girolamo Pelaia; Giuseppe Valenti; Nunzio Crimi
Journal:  Biomedicines       Date:  2021-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.